Drug Profile
Panadiplon
Alternative Names: FD 10571; FG 10571; NNC 140571; U 78875Latest Information Update: 09 Nov 1995
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Developer Novo Nordisk; Pharmacia Corporation
- Class Anxiolytics; Oxadiazoles; Quinoxalines; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 09 Nov 1995 Discontinued-I for Anxiety disorders in Denmark (Unknown route)
- 09 Nov 1995 Discontinued-I for Anxiety disorders in USA (Unknown route)